Asya Biomedical
Effective ophthalmological treatments address complications associated with diabetes-related eye issues.
Effective ophthalmological treatments address complications associated with diabetes-related eye issues.
Asya Biomedical is a Turkish startup founded in 2016, focusing on biotechnology, deep tech, and life sciences industries. The company's slogan centers around the effective treatment of diabetes-related eye complications. Their mission revolves around addressing ophthalmologic issues arising from diabetes. Despite their impactful vision, there is no record of last investment or last investment investors. With a concerted focus on innovating ophthalmological treatments, Asya Biomedical presents a compelling proposition in the biotechnology and life sciences sectors.
There is no investment information
No recent news or press coverage available for Asya Biomedical.
-logo.png){kind=logo}
We care about your data, and we'd love to use cookies make your experience better.
